Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT
Bone Marrow Transplant. 2024 Nov;59(11):1631-1634.
doi: 10.1038/s41409-024-02401-4.
Epub 2024 Aug 27.
1 Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
2 EBMT Statistical Unit, Leiden, The Netherlands.
3 University of Cologne, Cologne, Germany.
4 Hematology Department, CHU Montpellier, UMR5535, Université de Montpellier, Montpellier, France.
5 CHU de Lille, Lille, France.
6 Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
7 CHU Bordeaux, Hopital Haut-Leveque, Pessac, France.
8 Hospital Universitario de Salamanca (Spain), IBSAL, CIBERONC. Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.
9 Royal Marsden Hospital, London, UK.
10 Universita Cattolica S. Cuore, Rome, Italy.
11 University Hospital Schleswig-Holstein, Kiel, Germany.
12 Universitaet Tuebingen, Tuebingen, Germany.
13 University Medical Center Mainz, Mainz, Germany.
14 EBMT Leiden Study Unit, Leiden, The Netherlands.
15 Karolinska University Hospital, Stockholm, Sweden.
16 Département d'Oncologie, Service d'Hématologie et Service d'Immuno-Oncologie, CHUV Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
17 Département d'Oncologie, Service d'Hématologie, Geneva, Switzerland.
18 Institut Paoli-Calmettes Comprehensive Cancer Centre and Module Biothérapies du Centre d'Investigations Cliniques de Marseille, INSERM-Aix-Marseille Université-AP-HM-IPC, CBT-1409, Marseille, France.
19 University Medical Center Utrecht, Utrecht, The Netherlands.
20 San Raffaele Scientific Institute, Hematology and Bone Marrow Transplantation Unit, Milan, Italy.
21 Sorbonne Université, Centre de Recherche Saint-Antoine INSERM UMRs938, Paris, France. [email protected].
22 Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France. [email protected].